Current news

Jenni Vuola has started as a new board member of Pharmatest Services. She holds a PhD in microbiology and is

We’re excited to be part of Women’s Health Hub Finland (WHHF), an initiative driving innovation in female-focused healthcare (https://businessturku.fi/en/womens-health-hub-finland/). As

We’re proud to share that Pharmatest will participate in the Norwegian Conference for Hereditary Neuromuscular Disorders 2025, a premier gathering

Pharmatest is proud to participate in the ASBMR Annual Meeting 2025 and the 2025 ASBMR/RBDA Symposium on Rare Bone Diseases: From

We are excited to announce our participation in the BIO International Convention, Boston, MA, USA, Boston Convention & Exhibition Center,

AACR 2025 will be in Chicago this year and Pharmatest is participating, April 25-30! You can meat our team (Jukka

Pharmatest will participate the OARSI 2025 World Congress on Osteoarthritis in South Korea, April 24-27! This congress is an annual

Pharmatest will have a busy conference season! You can meet us in the following occasions: OARSI 2025 World Congress on

As we approach the end of another remarkable year, we want to take a moment to express our heartfelt gratitude

Pharmatest chosen for the TOP 60 companies of Kasvu Open program Kasvu Open aims at supporting the selected companies in

The Fruitful Collaboration of the Nordic EUROSTARS Consortium Continues Pharmatest Services is proud to be a partner in the NK-ENGAGE

Pharmatest will participate in ASBMR Annual Meeting 2024 and Rare Bone Disease Symposium on Exploring and Expanding Treatments and Analytical

We are delighted to announce that Pharmatest has successfully renewed its ISO 9001 certification. ISO 9001 is an internationally recognized

Pharmatest chosen for the Kasvu Open program Kasvu Open aims at supporting the selected companies in their journey towards growth.

Pharmatest obtained a bronze medal from EcoVadis assessment Sustainability is an essential factor for business nowadays. Pharmatest is aiming at

We are happy to announce that we will participate the AACR Annual Meeting 2024! You are welcome to visit our

The destabilization of the medial meniscus (DMM) mouse model is a widely used surgical model in osteoarthritis research to study

Pharmatest Services is part of the NK-ENGAGE project (Novel Synthetic Polypeptides for Natural Killer Cell -mediated Immunotherapy for the Treatment

We are delighted to announce our participation in ASBMR 2023 Annual Meeting. The meeting will take place in Vancouver, Canada

New study assessing bone health effects of radium-223, abiraterone acetate, prednisone, and zoledronic acid combo treatment in prostate cancer bone

Pharmatest Services’ Journey of Advancing Drug Discovery Pharmatest is thrilled to mark a significant milestone in our journey – our

We will be presenting three abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2023 held in Orlando April

Proud to present the results of our latest collaboration with Bayer AG and Aurexel Life Sciences! Our newest article, published

Breast cancer is the most common cancer globally, according to the World Health Organization. It accounts for 12% of all

The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific, and medical society with approximately 4,000 members

Pharmatest is excited to join the meeting onsite from April 8 through 13, 2022 at the Ernest N. Morial Convention

As 2021 is coming to an end, we would like to thank all of our customers, partners and employees for

Early detection saves lives October is Breast Cancer Awareness month. It is an important cause to raise awareness and understanding

We are delighted to announce that Pharmatest is now an ISO 9001:2015 certified company. This is an internationally recognized standard

Myeloma bone disease is still incurable and is characterized by destructive osteolytic lesions causing bone pain, fractures, and hypercalcemia. Our